Abstract
We report three cases of intracardiac thrombi in preterm infants of very low birth weight, in whom local low-dose urokinase treatment achieved complete thrombolysis without any signs of systemic fibrinolytic activity or side-effects.
Conclusion This new treatment strategy seems to be safe, requires minimal monitoring of fibrinolytic activity, and may be a new option for thrombolysis in high-risk patients such as premature infants, patients recently operated on, and patients presenting with other contra-indications for systemic fibrinolytic therapy.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 4 November 1998 / Accepted in revised form: 5 February 1999
Rights and permissions
About this article
Cite this article
Aspesberro, F., Beghetti, M., Oberhänsli, I. et al. Local low-dose urokinase treatment of acquired intracardiac thrombi in preterm infants. Eur J Pediatr 158, 698–701 (1999). https://doi.org/10.1007/s004310051182
Issue Date:
DOI: https://doi.org/10.1007/s004310051182